Need for a better characterization of HHV-6 infections and associated clinical impacts

P Bonnafous; J Marlet; C Gaudy-Graffin; A Gautheret-Dejean

doi:10.1111/ajt.15013

Need for a better characterization of HHV-6 infections and associated clinical impacts

Am J Transplant. 2019 Jan;19(1):304-305. doi: 10.1111/ajt.15013. Epub 2018 Aug 1.

Authors

P Bonnafous¹, J Marlet^{2

3}, C Gaudy-Graffin^{2

3}, A Gautheret-Dejean^{1

4

5}

Affiliations

¹ CIMI-Paris UMRS CR7, Inserm U1135, Equipe 1 Infections Virales Persistantes, Faculté de médecine, Sorbonne Université, Paris, France.
² Morphogenèse et Antigénicité du VIH et des Virus des Hépatites, Inserm U1259, Université de Tours, Tours, France.
³ Laboratoire de Bactériologie-Virologie-Hygiène, CHU de Tours, Tours, France.
⁴ Service de Virologie, HU La Pitié Salpêtrière-Charles Foix, APHP, Paris, France.
⁵ Laboratoire de Microbiologie, équipe UPRES EA4065, Faculté de Pharmacie, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

PMID: 29985560
DOI: 10.1111/ajt.15013

No abstract available

Keywords: clinical research/practice; complication: infectious; infection and infectious agents-viral: human herpesvirus 6 (HHV-6); intestinal disease: infectious; liver transplantation/hepatology; molecular biology: DNA; organ transplantation in general.

Publication types

Letter
Comment

MeSH terms

Fatal Outcome
Herpesviridae Infections*
Herpesvirus 6, Human*
Humans
Immunosuppressive Agents
Liver Transplantation*

Substances

Immunosuppressive Agents